Strategies for the elimination of taeniasis/cysticercosis.
Advances in the field of neurocysticercosis continue to shape our understanding of the disease and our efforts to control it. Several attempts have been made to eradicate the disease with active interventions such as changing domestic pig-raising practices, mass chemotherapy of porcine cysticercosis and taeniasis, selective detection and treatment of taeniasis, and community health education. Moreover, ongoing progress in the diagnosis of taeniasis and the development of a porcine vaccine against cysticercosis in Australia, Mexico and Peru has yielded at least one effective vaccine that is currently available. Thus far, however, attempted interventions have only been successful in temporarily disrupting transmission of the disease. Controlled data on the efficacy and acceptability of the different interventions is urgently needed to provide a base-line schematic for intervention which could later be tailored to each particular endemic scenario.
Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru. hgarcia@terra.com.pe
Héctor H
HH
García
Armando E
AE
González
Oscar H
OH
Del Brutto
Victor C W
VC
Tsang
Fernando
F
Llanos-Zavalaga
Guillermo
G
Gonzalvez
Jaime
J
Romero
Robert H
RH
Gilman
D000818:Animals; D000923:Anticestodal Agents / Q000627:therapeutic use; D001921:Brain / Q000469:parasitology / Q000473:pathology; D006266:Health Education; D006801:Humans; D020019:Neurocysticercosis / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control*; D010273:Parasitic Diseases, Animal / Q000188:drug therapy; D010568:Peru / Q000453:epidemiology; D034421:Sus scrofa / Q000469:parasitology; D013553:Swine Diseases / Q000188:drug therapy; D013622:Taeniasis / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D014612:Vaccines / Q000592:standards / Q000627:therapeutic use
D000923:Anticestodal Agents; D014612:Vaccines